Considering that TGF-β1 promotes the progression of breast cancer at advanced stages [3, 4], we assumed that miRNA expression inhibited by TGF-β1 must have antitumor potential, as previously demonstrated for miR-450b-5p [8] and miR-411-5p [9]. Here, TGFB1 is linked to breast cancer.